Your shopping cart is empty!
Clinical and Laboratory Standards Institute, 11/01/1996
Publisher: CLSI
File Format: PDF
$113.00$227.95
Published:01/11/1996
Pages:40
This document contains recommendations for the measurement, reporting, and interpretation of erythrocyte protoporphyrin using hematofluorometric and extraction measurement methods.
The U.S. Food and Drug Administration (FDA) has evaluated and recognized this approved-level consensus guideline for use in satisfying a regulatory requirement.
Immunoassay Systems: Radioimmunoassays and Enzyme, Fluorescence, and Luminescence Immunoassays; Approved Guideline, ILA23AE
$148.00 $297.72
Clinical Use and Interpretation of Serologic Tests for Toxoplasma gondii; Approved Guideline, M36AE
$132.00 $264.43
Antiviral Susceptibility Testing: Herpes Simplex Virus by Plaque Reduction Assay; Approved Standard, M33AE
$120.00 $240.30
Quality Control of Microbiological Transport Systems; Approved Standard, M40A
$142.00 $285.39